In transgenic SIRT1 mice, lower SIRT1 levels encouraged antioxidative activity, whereas greater levels caused cardiomyopathy, possibly as a compensatory reaction to increased antioxidant levels [177]. Here, SIRT1 is linked to cardiomyopathy.